1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 280 F.Supp.3d
  5. 280 F.Supp.3d 217 (2017)
 

U.S. v. AEGERION PHARMACEUTICALS, INC.

Criminal Action No. 17-10288-WGY.

280 F.Supp.3d 217 (2017)

UNITED STATES of America, v. AEGERION PHARMACEUTICALS, INC., Defendant.

United States District Court, D. Massachusetts.

Signed November 20, 2017.

Attorney(s) appearing for the Case

Kriss Basil , Young Paik , United States Attorney's Office MA, Boston, MA, Shannon Pedersen , United States Department of Justice, Washington, DC, for Plaintiff.

Joshua S. Levy , Patrick J. Welsh , Ropes & Gray LLP, Boston, MA, for Defendant.

MEMORANDUM & ORDER

Let's see if I've got this straight.1

Aegerion Pharmaceuticals, Inc. ("Aegerion") developed an effective medicine, called Juxtapid, to treat high cholesterol in people with a rare genetic disease. The treatment did not come cheap. "At market launch...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases